Monitoring clinical trials for immune tolerance research
Official title: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC)
Funded at Ppd Development LP · NIH-11095705 · Data updated 2026-11-12
This study is all about keeping a close eye on clinical trials that explore how our immune system can learn to ignore certain things, and it's designed for patients who might benefit from new treatments that help manage immune responses safely and effectively.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ppd Development LP NIH-funded |
| Lab location | 1 site (Wilmington, United States) |
| Project start | June 30, 2022 |
| Project end | June 29, 2025 |
| Funding year | 2024 |
| Award (this year) | $7,462,349 |
| NIH project number | 75N93022C00014-P00003-9999-1 |
| Project ID | NIH-11095705 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals with conditions that may benefit from enhanced immune tolerance, such as autoimmune disorders or allergies.
✕Less likely to help
Patients with conditions unrelated to immune tolerance or those not participating in the monitored trials may not receive direct benefits from this research.
What this research studies
This research focuses on providing thorough monitoring services for clinical trials aimed at understanding immune tolerance, which is how the immune system can be unresponsive to certain antigens. The project ensures that these trials comply with federal regulations and international standards, thereby safeguarding participant welfare and data integrity. Patients involved in these trials may experience cutting-edge treatments that explore how to manage immune responses effectively. The monitoring services also extend to other investigator-initiated studies, enhancing the overall quality of clinical research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for conditions related to immune tolerance, potentially benefiting patients with autoimmune diseases or allergies.
How similar studies have gone: Previous research in immune tolerance has shown promising results, indicating that this approach has the potential for significant advancements in treatment.
Where this research is happening
-
Ppd Development LP
Wilmington, United States Active
Researchers
- Principal investigator: Glessner, Mary — Ppd Development LP
- Study coordinator: Glessner, Mary
Related research
Other NIH-funded projects on the same topics.
-
New Horizons in preventing and treating food allergy
A Johns Hopkins-led effort aims to advance how we prevent and treat food allergies across all ages by coordinating high-quality studies and developing better therapies.
-
Understanding antibiotic allergy to improve care for patients
Scientists are testing new ideas to understand why some people develop severe allergic reactions to antibiotics and how to prevent or treat them.
-
Antibiotic Allergy: Types, Triggers, and How they Work
This grant aims to better understand why certain antibiotics trigger immediate allergic reactions and how to improve testing and diagnosis for patients with suspected antibiotic allergies.
-
Understanding alpha-gal meat allergy and how the body's immune system reacts
This grant studies why some people develop a dangerous allergy to meat due to a molecule called alpha-gal and how it triggers life-threatening reactions.
-
New Horizons in Food Allergy Prevention and Treatment
A large, multi-site program at Johns Hopkins aims to advance prevention and treatment of food allergies across all ages.
-
Food allergy outcomes by race/ethnicity from infancy through adolescence
This study follows children with food allergies over time to understand how race and ethnicity relate to allergy management, outcomes, and quality of life.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.